Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 8, 2003. The report serves as a notification of changes in directors' interests in the company's Ordinary Shares and does not contain financial performance data for a specific fiscal period.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of share transactions and does not include financial statements.
Material Changes
The filing details two specific types of changes in share ownership:
- Trust Transfer: On July 4, 2003, the GlaxoSmithKline Employee Trust transferred 1,289 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Director Purchases: On July 3, 2003, several directors and connected persons purchased Ordinary Shares via a Single Company ISA at a price of £12.10 per share.
Outlook and Risks
The filing contains no management commentary, guidance, outlook, risks, contingencies, or unusual items. The document is limited to regulatory disclosure of shareholding changes.
Key Facts for Investors
- Share Price: Directors purchased shares at £12.10 per Ordinary Share on July 3, 2003.
- Director Purchases: Mr. J D Coombe and his wife, Mrs. G A Coombe, each purchased 3 shares. Sir Peter Job purchased 6 shares.
- Trust Activity: The GSK Trust, which benefits employees and former employees, distributed 1,289 shares to plan participants.
- Director Interests: Directors Dr. J-P Garnier and Mr. J D Coombe hold interests in the GSK Trust shares in the same capacity as other employees.